Chronic Subdural Hematoma Clinical Trials
2 recruiting trials for Chronic Subdural Hematoma. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Chronic Subdural Hematoma clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Region Skane (1), Huashan Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Endovascular treatment of the middle meningeal artery (procedure, 1 trial), followed by Standard neurosurgical hematoma evacuation, Intracranial Hypotension Targeted(IHT) Body Posture.
Track Chronic Subdural Hematoma trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Swedish Trial on Embolization of Middle Meningeal Artery Versus Surgical Evacuation in Chronic Subdural Hematoma
The SWEMMA trial is an open, national, multi-center, prospective, randomized (1:1), superiority trial designed to assess impact on reoperation rates for chronic subdural hematoma...
The Effectiveness and Safety of Body Posture in Preventing Postoperative Recurrence for Chronic Subdural Hematoma
This study aims to investigate the effectiveness and safety of body posture to improve intracranial pressure in preventing postoperative recurrence for chronic subdural hematoma
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Chronic Subdural Hematoma, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Chronic Subdural Hematoma, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Chronic Subdural Hematoma, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.